These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18235107)

  • 1. Glandular function in Sjögren syndrome: assessment with dynamic contrast-enhanced MR imaging and tracer kinetic modeling--initial experience.
    Roberts C; Parker GJ; Rose CJ; Watson Y; O'Connor JP; Stivaros SM; Jackson A; Rushton VE
    Radiology; 2008 Mar; 246(3):845-53. PubMed ID: 18235107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of T1ρMR imaging in Sjögren's syndrome with normal appearing parotid glands: Initial findings.
    Chu C; Zhou N; Zhang H; Dou X; Li M; Liu S; Zhu Y; Chen W; Chan Q; He J; Sun L; Zhou Z
    J Magn Reson Imaging; 2017 Apr; 45(4):1005-1012. PubMed ID: 27726238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced MR imaging of the breast at 3.0 and 1.5 T in the same patients: initial experience.
    Kuhl CK; Jost P; Morakkabati N; Zivanovic O; Schild HH; Gieseke J
    Radiology; 2006 Jun; 239(3):666-76. PubMed ID: 16549623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging.
    Fütterer JJ; Heijmink SW; Scheenen TW; Veltman J; Huisman HJ; Vos P; Hulsbergen-Van de Kaa CA; Witjes JA; Krabbe PF; Heerschap A; Barentsz JO
    Radiology; 2006 Nov; 241(2):449-58. PubMed ID: 16966484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of malignant from benign pheochromocytomas with diffusion-weighted and dynamic contrast-enhanced magnetic resonance at 3.0 T.
    Dong Y; Liu Q
    J Comput Assist Tomogr; 2012; 36(4):361-6. PubMed ID: 22805661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility study of using intravoxel incoherent motion mri to detect parotid gland abnormalities in early-stage Sjögren syndrome patients.
    Su GY; Xu XQ; Wang YY; Hu H; Shen J; Hong XN; Shi HB; Wu FY
    J Magn Reson Imaging; 2016 Jun; 43(6):1455-61. PubMed ID: 26583877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of dynamic contrast-enhanced MR imaging to predict survival in patients with primary breast cancer undergoing neoadjuvant chemotherapy.
    Li SP; Makris A; Beresford MJ; Taylor NJ; Ah-See ML; Stirling JJ; d'Arcy JA; Collins DJ; Kozarski R; Padhani AR
    Radiology; 2011 Jul; 260(1):68-78. PubMed ID: 21502383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging--initial experience.
    Buckley DL; Roberts C; Parker GJ; Logue JP; Hutchinson CE
    Radiology; 2004 Dec; 233(3):709-15. PubMed ID: 15498903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging of the parotid gland in patients with Sjögren's syndrome.
    Späth M; Krüger K; Dresel S; Grevers G; Vogl T; Schattenkirchner M
    J Rheumatol; 1991 Sep; 18(9):1372-8. PubMed ID: 1757940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic architectural and dynamic features at breast MR imaging: multicenter study.
    Schnall MD; Blume J; Bluemke DA; DeAngelis GA; DeBruhl N; Harms S; Heywang-Köbrunner SH; Hylton N; Kuhl CK; Pisano ED; Causer P; Schnitt SJ; Thickman D; Stelling CB; Weatherall PT; Lehman C; Gatsonis CA
    Radiology; 2006 Jan; 238(1):42-53. PubMed ID: 16373758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative Analysis of Parotid Gland Secretion Function in Sjögren's Syndrome Patients with Dynamic Magnetic Resonance Sialography.
    Liu S; Chen W; Wang M; Wu T; Dong L; Pan C; Zhu W
    Korean J Radiol; 2019 Mar; 20(3):498-504. PubMed ID: 30799581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Added Value of Parotid R2* Values for Evaluation of Sjögren Syndrome: A Preliminary Study.
    Chu C; Zhou N; Zhang H; Dou X; Li M; Liu S; Wang J; Chen W; Chan Q; Sun L; He J; Zhou Z
    J Comput Assist Tomogr; 2017; 41(4):547-552. PubMed ID: 28722699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soft-tissue tumors: value of static and dynamic gadopentetate dimeglumine-enhanced MR imaging in prediction of malignancy.
    van Rijswijk CS; Geirnaerdt MJ; Hogendoorn PC; Taminiau AH; van Coevorden F; Zwinderman AH; Pope TL; Bloem JL
    Radiology; 2004 Nov; 233(2):493-502. PubMed ID: 15459325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose.
    Manka C; Träber F; Gieseke J; Schild HH; Kuhl CK
    Radiology; 2005 Mar; 234(3):869-77. PubMed ID: 15665227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sjögren's syndrome of the parotid gland: value of diffusion-weighted echo-planar MRI for diagnosis at an early stage based on MR sialography grading in comparison with healthy volunteers.
    Regier M; Ries T; Arndt C; Cramer MC; Graessner J; Reitmeier F; Jaehne M; Adam G; Habermann CR
    Rofo; 2009 Mar; 181(3):242-8. PubMed ID: 19229790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic tibiofibular syndesmosis injury of ankle: evaluation with contrast-enhanced fat-suppressed 3D fast spoiled gradient-recalled acquisition in the steady state MR imaging.
    Kim S; Huh YM; Song HT; Lee SA; Lee JW; Lee JE; Chung IH; Suh JS
    Radiology; 2007 Jan; 242(1):225-35. PubMed ID: 17185669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of acute benign and malignant vertebral body fractures using dynamic contrast-enhanced MRI.
    Geith T; Biffar A; Schmidt G; Sourbron S; Dürr HR; Reiser M; Baur-Melnyk A
    AJR Am J Roentgenol; 2013 Jun; 200(6):W635-43. PubMed ID: 23701095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between intravoxel incoherent motion MR parameters and MR nodular grade of parotid glands in patients with Sjögren's syndrome: A pilot study.
    Chu C; Zhou N; Zhang H; Dou X; Li M; Liu S; Zhu Y; Chen W; Chan Q; He J; Sun L; Zhou Z
    Eur J Radiol; 2017 Jan; 86():241-247. PubMed ID: 28027754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution.
    Kuhl CK; Schild HH; Morakkabati N
    Radiology; 2005 Sep; 236(3):789-800. PubMed ID: 16118161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of clinicopathologic response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging: initial clinical results.
    Padhani AR; Hayes C; Assersohn L; Powles T; Makris A; Suckling J; Leach MO; Husband JE
    Radiology; 2006 May; 239(2):361-74. PubMed ID: 16543585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.